Inspections, Compliance, Enforcement, and Criminal Investigations
CVS Pharmacy, Inc. - Close out letter
| Public Health Service Food and Drug Administration |
| New England District One Montvale Avenue Stoneham, Massachusetts 02180 (781) 596-7700 FAX: (781) 596-7896 |
Department of Health and Human ServicesDate: December 21, 2010
Mr. Tom Ryan, CEO
CVS Corporation
1 CVS Drive
Woonsocket, RI 02895
Dear Mr. Ryan:
The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter NWE-20-10W dated September 27, 2010. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Anthony Costello
Compliance Officer
New England District
